Gut Pathogens
Cure8 research brief
Limited source text
What Cure8 can confirm
What We Know
Cure8 does not have enough reliable source text to summarize this article yet. Based on the article title and source metadata, this appears to be a clinical study related to Inflammatory bowel disease, Microbiome, and Research and clinical trials. Use the original source link for the full details.
What Is Not Available
The source did not provide enough reliable article text for a source-grounded Cure8 brief. Study details, results, and limitations should be checked in the original source.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationGut Pathogens
PublisherSpringer Science and Business Media LLC
AuthorsXuefei Zhao, Minjia Chen, Ting Li +10 more
Study typeJournal Article
Indexed viaCrossref
Source typeResearch paper
PublishedOct 5, 2026, 12:00 AM
Content availableMetadata only
Funding disclosed by the source: Chongqing Science and Health Joint Project, award 2020MSXM017; Chongqing Science and Health Joint Project, award 2024ZDXM010; National Natural Science Foundation of China (NSFC) Project, award 82370539; Chongqing Talent Innovation and Entrepreneurship Leading Talent Program, award CQYC20220303576; Chongqing Municipal Education Commission Science and Technology Research Project, award KJZD-K202512807
Cure8 could not retrieve enough reliable source text to summarize this article. This page is based on the article title, source metadata, and Cure8 topic classification.
Gut microbiota and ulcerative colitis: a transcriptomic and Mendelian randomization study
Based on the title and source metadata, this appears to be a clinical study related to Ulcerative colitis, Inflammatory bowel disease, and Microbiome. The original article is from AMB Express.
Development and Evaluation of Carvacrol-Pectin/Chitosan Complex for Colon Targeted Drug Delivery in Ulcerative Colitis
New colon-targeted formulations aim to concentrate treatment where inflammation is in ulcerative colitis, which could increase benefit and reduce systemic side effects. Formulation research like this is an early step...
FUT2-mediated α1,2-fucosylation in inflammatory bowel disease: mechanisms and translational potential
FUT2-mediated fucosylation shapes gut glycans and the microbiome, mechanisms relevant to inflammation and mucosal barrier function in IBD. Understanding these pathways could point to future biomarkers or therapeutic...